Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €91.86 EUR
Change Today +0.66 / 0.73%
Volume 42.2K
NOT On Other Exchanges
New York
SIX Swiss Ex
SIX Swiss Ex
As of 2:22 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark C. Fishman M.D.

President of Institutes for Biomedical Research (NIBR), Novartis AG
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 5 different industries.

As of Fiscal Year 2014


Dr. Mark C. Fishman, MD serves as Global Head of The Novartis Institute for BioMedical Research (NIBR) at Novartis AG and served as its President of BioMedical Research (NIBR) since 2002. Dr. Fishman serves as a Consultant in Medicine at the MGH. He serves as the President of BioMedical Research of Novartis Consumer Health, Inc. He has been the President of the Novartis Institutes for BioMedical Research (NIBR) of Novartis Institutes for BioMedical Research, Inc. since ...

Read Full Background

Corporate Headquarters*

Lichtstrasse 35
Basel, Basel-Stadt 4056


Phone: 41 61 324 11 11
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.


MD 1976
Harvard Medical School
BA 1972
Yale College

Other Affiliations*

Annual Compensation*

Total Annual Compensation$3,009,618

Stock Options*

Long Term Incentive Plan$2,772,067
All Other Compensation$372,941

Total Compensation*

Total Annual Cash Compensation$3,382,559
Total Short Term Compensation$3,009,618
Other Long Term Compensation$372,941
Total Calculated Compensation$6,154,626
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOT:GR €91.86 EUR +0.66


John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at